Last updated: 2026-11-14 20:20:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Intuitive Surgical Inc. (ISRG) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $443.60, with a market capitalization of $152.49B and a P/E ratio of 51.56. Over the past 52 weeks, its price has ranged from $328.57 to $603.88. This page covers its latest market performance, valuation, price trends and company information.
$152.49B | |
$443.69 | |
$448.99 | |
$441.10 | |
$439.89 | |
1.18M | |
2.37M | |
51.56 | |
$603.88 | |
$328.57 | |
-- | |
12-31 |
Intuitive Surgical Inc. (ISRG) last closed at $443.60 as of 2026-11-14 01:00:00, up 0.81% ($3.58) from the previous close of $439.89.
During the latest regular trading session, ISRG traded between $441.10 and $448.99, with a volume of 1.18M shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Intuitive Surgical Inc. (ISRG) moved from $468.52 to $443.60, representing a decline of 5.32% ($24.92).
The stock traded between $438.44 and $485.17 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.26 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 41.8%
ISRG is currently trading at $443.60, placing it 41.8% of the way from its 52-week low of $328.57 to its 52-week high of $603.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 17,021 |
| CEO | David J. Rosa |
| Founded | 1995 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Intuitive Surgical Inc. and ISRG stock.
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 20 years by 11.51% on an annualized basis producing an average annual return of 20.31%. Currently, Intuitive Surgical has a market
10x Genomics announced that Fudan University Shanghai Cancer Center and Shanghai Precision Diagnostics will use its Xenium platform in a 24-month breast cancer biomarker study analyzing tumor biopsies from 500 patients. The collaboration aims to identify biomarkers predicting treatment response to neoadjuvant therapy, potentially advancing personalized cancer diagnostics. TXG stock has surged 264.7% year-to-date, outperforming broader markets.
AMN Healthcare (AMN) is well-positioned for growth driven by strong healthcare staffing demand, MSP opportunities, and technology investments, with Nurse and Allied revenues rising 27% in Q3. However, the stock faces headwinds from visa delays affecting international nurse placements, pricing pressures, and weakness in Physician and Technology segments. The company holds a Zacks Rank #3 (Hold) rating despite surging 140.5% year-to-date.
Merit Medical Systems announced positive real-world clinical data from its WRAPSODY Cell-Impermeable Endoprosthesis, demonstrating 92.7% six-month target lesion primary patency and 76.7% access circuit primary patency, both exceeding WAVE trial results. The device received FDA approval in December 2024 and is now being commercialized in the U.S., with ongoing registry studies expected to generate comprehensive clinical evidence supporting wider physician adoption in the growing dialysis access market.
Intuitive Surgical agreed to a $450 million no-fault settlement over third-party da Vinci servicing and instrument remanufacturing. While the settlement reduced Q3 GAAP EPS to $1.49, adjusted EPS rose 25% year-over-year to $3.00. Revenues grew 22% to $3 billion with procedures up 15%, demonstrating strong underlying operational momentum despite the litigation charge.
Eligible investors can buy real shares of Intuitive Surgical Inc. (ISRG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Browse other US stocks in the same sector as Intuitive Surgical Inc.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ISRG, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ISRG shares and USD.
ISRG Shares to USD
1.00 ISRG shares = 443.598 USD
Calculations are estimates based on the latest available price and are for reference only.
